MetaADEDB 2.0 @ LMMD
Alprazolam
(VREFGVBLTWBCJP-UHFFFAOYSA-N)
Structure
SMILES
Clc1ccc2c(c1)C(=NCc1n2c(C)nn1)c1ccccc1
Type(s)
Approved; Illicit; Investigational
ATC code(s)
N05BA12
Molecular Formula:
C17H13ClN4
Molecular Weight:
308.765
Log P:
3.0157
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
43.07
CAS Number(s):
28981-97-7; 51339-48-1
Synonym(s)
1.
Alprazolam
2.
Alprazolan
3.
Alprox
4.
Apo-Alpraz
5.
Cassadan
6.
D-65MT
7.
Esparon
8.
Kalma
9.
Novo-Alprazol
10.
Nu-Alpraz
11.
Ralozam
12.
Tafil
13.
Trankimazin
14.
U-31,889
15.
Xanax
16.
Apo Alpraz
17.
D65MT
18.
Novo Alprazol
19.
Nu Alpraz
20.
U31,889
External Link(s)
MeSHD000525
PubChem Compound2118
BindingDB50001728
ChEBI2611
CHEMBLCHEMBL661
DrugBankDB00404
DrugCentral136
IUPHAR/BPS Guide to PHARMACOLOGY7111
KEGGcpd:C06817
dr:D00225
Therapeutic Target DatabaseD0L9GG
ZINC903
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 1065
Canada Vigilance: 9
Canada Vigilance
OFFSIDES
US FAERS
2Drug abuseFAERS: 435US FAERS
3AnxietyFAERS: 398
Canada Vigilance: 7
Canada Vigilance
OFFSIDES
SIDER
US FAERS
4OverdoseFAERS: 353OFFSIDES
US FAERS
5Drug DependenceFAERS: 308
Canada Vigilance: 5
Canada Vigilance
US FAERS
6SomnolenceFAERS: 290
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
7SoporFAERS: 284US FAERS
8Feeling abnormalFAERS: 260
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
9MalaiseFAERS: 242
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
10Suicide attemptFAERS: 238
Canada Vigilance: 1
Canada Vigilance
US FAERS
11HeadacheFAERS: 222
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
12Accidental overdoseFAERS: 204US FAERS
13DizzinessFAERS: 188
Canada Vigilance: 4
2307974
2873131
18635690
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
14Completed SuicideFAERS: 165SIDER
US FAERS
15Drug withdrawal syndromeFAERS: 161
Canada Vigilance: 4
Canada Vigilance
US FAERS
16Toxicity to various agentsFAERS: 159US FAERS
17TremorFAERS: 157
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
18NauseaFAERS: 156
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
19FatigueFAERS: 106
Canada Vigilance: 1
3358644
18635690
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
20Intentional product misuseFAERS: 105
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Product substitution issueFAERS: 99
Canada Vigilance: 3
Canada Vigilance
US FAERS
22Product quality issueFAERS: 98
Canada Vigilance: 2
Canada Vigilance
US FAERS
23AmnesiaFAERS: 91
Canada Vigilance: 5
3358644
9467187
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
24Cardiac ArrestFAERS: 91US FAERS
25PainFAERS: 91
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
26PalpitationsFAERS: 91
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
27VomitingFAERS: 89SIDER
US FAERS
28NervousnessFAERS: 86
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
29Respiratory arrestFAERS: 85US FAERS
30AgitationFAERS: 80
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
31Medication ErrorFAERS: 80US FAERS
32AstheniaFAERS: 78
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
33Intentional self-injuryFAERS: 77US FAERS
34Pharmaceutical product complaintFAERS: 74OFFSIDES
US FAERS
35Drug ineffective for unapproved indicationFAERS: 70
Canada Vigilance: 1
Canada Vigilance
US FAERS
36Memory impairmentFAERS: 69SIDER
US FAERS
37Weight decreasedFAERS: 63
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
38Drug effect incompleteFAERS: 60US FAERS
39Therapeutic response unexpectedFAERS: 57US FAERS
40Depressed Level of ConsciousnessFAERS: 55
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
41Abdominal discomfortFAERS: 52OFFSIDES
SIDER
US FAERS
42AngerFAERS: 52OFFSIDES
SIDER
US FAERS
43Product taste abnormalFAERS: 52US FAERS
44CryingFAERS: 50US FAERS
45HypersensitivityFAERS: 49
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
46Incorrect dose administeredFAERS: 48OFFSIDES
US FAERS
47Chest PainFAERS: 47OFFSIDES
SIDER
US FAERS
48DysgeusiaFAERS: 45US FAERS
49PruritusFAERS: 45
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
50PoisoningFAERS: 42US FAERS
51Product use issueFAERS: 42US FAERS
52TachycardiaFAERS: 422307974
10389047
CTD
SIDER
US FAERS
53Visual ImpairmentFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
54nervous system disorderFAERS: 42SIDER
US FAERS
55HypotensionFAERS: 4110389047CTD
SIDER
US FAERS
56Intentional product use issueFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Drug exposure during pregnancyFAERS: 40US FAERS
58VertigoFAERS: 40
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
59DependenceFAERS: 39OFFSIDES
US FAERS
60Myocardial InfarctionFAERS: 39
Canada Vigilance: 1
3224354CTD
Canada Vigilance
US FAERS
61StressFAERS: 39OFFSIDES
US FAERS
62Cerebrovascular accidentFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
63Drug ToleranceFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
64DeliriumFAERS: 36

View details

CTD
US FAERS
65DysarthriaFAERS: 36SIDER
US FAERS
66DisorientationFAERS: 35SIDER
US FAERS
67Drug dispensing errorFAERS: 35US FAERS
68Activities of daily living impairedFAERS: 34OFFSIDES
US FAERS
69Altered state of consciousnessFAERS: 34SIDER
US FAERS
70Pre-existing condition improvedFAERS: 34US FAERS
71Product use in unapproved indicationFAERS: 34US FAERS
72DyspepsiaFAERS: 33OFFSIDES
SIDER
US FAERS
73Therapeutic response unexpected with drug substitutionFAERS: 33US FAERS
74ParanoiaFAERS: 32
Canada Vigilance: 3
Canada Vigilance
US FAERS
75TinnitusFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
76UrticariaFAERS: 32
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
77Impaired work abilityFAERS: 30OFFSIDES
US FAERS
78Panic DisorderFAERS: 30

View details

CTD
SIDER
US FAERS
79Emotional disorderFAERS: 29US FAERS
80Suspected counterfeit productFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
81MyalgiaFAERS: 28SIDER
US FAERS
82Depressed moodFAERS: 27OFFSIDES
SIDER
US FAERS
83RestlessnessFAERS: 27US FAERS
84BradyphreniaFAERS: 26SIDER
US FAERS
85Drug screen positiveFAERS: 26US FAERS
86Impaired driving abilityFAERS: 26US FAERS
87ArthralgiaFAERS: 25SIDER
US FAERS
88ConstipationFAERS: 25SIDER
US FAERS
89Intentional drug misuseFAERS: 25US FAERS
90Product physical issueFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
91AbasiaFAERS: 22US FAERS
92Abdominal PainFAERS: 22SIDER
US FAERS
93Diabetes MellitusFAERS: 22US FAERS
94Feeling jitteryFAERS: 22SIDER
US FAERS
95LethargyFAERS: 22
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
96Mental status changesFAERS: 22OFFSIDES
US FAERS
97Back PainFAERS: 20SIDER
US FAERS
98Burning sensationFAERS: 20US FAERS
99HypersomniaFAERS: 20SIDER
US FAERS
100CatatoniaFAERS: 19US FAERS
101Drug abuserFAERS: 19US FAERS
102Wrong technique in product usage processFAERS: 19US FAERS
103Alcohol abuseFAERS: 18US FAERS
104Drug dose omissionFAERS: 18US FAERS
105FibromyalgiaFAERS: 18US FAERS
106Poor quality drug administeredFAERS: 18US FAERS
107BedriddenFAERS: 17US FAERS
108Drug prescribing errorFAERS: 17US FAERS
109GlaucomaFAERS: 17OFFSIDES
US FAERS
110Loss of personal independence in daily activitiesFAERS: 17US FAERS
111Irritable Bowel SyndromeFAERS: 16US FAERS
112Personality ChangeFAERS: 16US FAERS
113Post-Traumatic Stress DisorderFAERS: 16US FAERS
114Prescription drug used without a prescriptionFAERS: 16US FAERS
115Urinary RetentionFAERS: 16SIDER
US FAERS
116BradycardiaFAERS: 1510464538CTD
OFFSIDES
US FAERS
117BradykinesiaFAERS: 15US FAERS
118Chest discomfortFAERS: 15SIDER
US FAERS
119Drug toxicityFAERS: 15US FAERS
120ErythemaFAERS: 15OFFSIDES
US FAERS
121Mental impairmentFAERS: 15US FAERS
122Poor quality sleepFAERS: 15US FAERS
123Reaction to drug excipientsFAERS: 15US FAERS
124SyncopeFAERS: 15
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
125Unevaluable eventFAERS: 15US FAERS
126CataractFAERS: 14OFFSIDES
US FAERS
127Middle insomniaFAERS: 14OFFSIDES
US FAERS
128PneumoniaFAERS: 14US FAERS
129Throat irritationFAERS: 14US FAERS
130Adverse eventFAERS: 13US FAERS
131AgoraphobiaFAERS: 132651489
3358644
CTD
US FAERS
132AlopeciaFAERS: 13US FAERS
133Anaphylactic shockFAERS: 13US FAERS
134AtaxiaFAERS: 133358644
7802851
CTD
SIDER
US FAERS
135DehydrationFAERS: 13OFFSIDES
US FAERS
136Inappropriate schedule of drug administrationFAERS: 13US FAERS
137Mood swingsFAERS: 13SIDER
US FAERS
138Musculoskeletal stiffnessFAERS: 13OFFSIDES
SIDER
US FAERS
139MydriasisFAERS: 13SIDER
US FAERS
140Obsessive-Compulsive DisorderFAERS: 13US FAERS
141Poor quality product administeredFAERS: 13US FAERS
142Respiratory DepressionFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
143SwellingFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
144Alcohol interactionFAERS: 12US FAERS
145Atrial FibrillationFAERS: 1210389047CTD
US FAERS
146Blood glucose increasedFAERS: 12US FAERS
147DementiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
148DiscomfortFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
149EpilepsyFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
150Eye painFAERS: 12US FAERS
151PhotophobiaFAERS: 12SIDER
US FAERS
152Blood cholesterol increasedFAERS: 11US FAERS
153DysgraphiaFAERS: 11US FAERS
154Erectile dysfunctionFAERS: 11US FAERS
155Feeling ColdFAERS: 11US FAERS
156InfectionFAERS: 11SIDER
US FAERS
157Angina PectorisFAERS: 10US FAERS
158ArthritisFAERS: 10OFFSIDES
US FAERS
159ArthropathyFAERS: 10OFFSIDES
US FAERS
160Drug administration errorFAERS: 10US FAERS
161Euphoric moodFAERS: 10SIDER
US FAERS
162Exposure via ingestionFAERS: 10US FAERS
163General physical health deteriorationFAERS: 10OFFSIDES
US FAERS
164Muscle tightnessFAERS: 10US FAERS
165Nerve injuryFAERS: 10US FAERS
166NeuralgiaFAERS: 10OFFSIDES
US FAERS
167Product shape issueFAERS: 10US FAERS
168Product solubility abnormalFAERS: 10US FAERS
169SluggishnessFAERS: 10SIDER
US FAERS
170Temperature intoleranceFAERS: 10US FAERS
171ThirstFAERS: 10SIDER
US FAERS
172Urinary IncontinenceFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
173Victim of chemical submissionFAERS: 10US FAERS
174Accidental exposure to productFAERS: 9US FAERS
175Alcohol poisoningFAERS: 9US FAERS
176AsthmaFAERS: 9OFFSIDES
US FAERS
177Back disorderFAERS: 9US FAERS
178Blood creatine phosphokinase increasedFAERS: 9US FAERS
179DiplopiaFAERS: 9SIDER
US FAERS
180Emotional distressFAERS: 9OFFSIDES
US FAERS
181EpistaxisFAERS: 9SIDER
US FAERS
182HyperventilationFAERS: 9SIDER
US FAERS
183HypokinesiaFAERS: 9US FAERS
184Pulmonary EmbolismFAERS: 9US FAERS
185Slow speechFAERS: 9US FAERS
186ThrombosisFAERS: 9US FAERS
187ApathyFAERS: 8OFFSIDES
SIDER
US FAERS
188Apparent deathFAERS: 8US FAERS
189Bipolar DisorderFAERS: 8
Canada Vigilance: 1

View details

CTD
OFFSIDES
Canada Vigilance
US FAERS
190Blood potassium decreasedFAERS: 8OFFSIDES
US FAERS
191Cold sweatFAERS: 8SIDER
US FAERS
192Counterfeit product administeredFAERS: 8US FAERS
193DeafnessFAERS: 8OFFSIDES
US FAERS
194Drug effect delayedFAERS: 8US FAERS
195Drug screen negativeFAERS: 8US FAERS
196Drug withdrawal convulsionsFAERS: 8
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
197Expired product administeredFAERS: 8US FAERS
198HomicideFAERS: 8US FAERS
199HostilityFAERS: 8OFFSIDES
SIDER
US FAERS
200InfluenzaFAERS: 8SIDER
US FAERS
201Life expectancy shortenedFAERS: 8US FAERS
202Maternal exposure during pregnancyFAERS: 8US FAERS
203Neck PainFAERS: 8US FAERS
204Negative thoughtsFAERS: 8US FAERS
205No adverse eventFAERS: 8US FAERS
206ParamnesiaFAERS: 8
Canada Vigilance: 7
Canada Vigilance
US FAERS
207Physical assaultFAERS: 8OFFSIDES
US FAERS
208Psychiatric symptomFAERS: 8OFFSIDES
US FAERS
209Respiratory distressFAERS: 8US FAERS
210Restless Legs SyndromeFAERS: 8US FAERS
211SnoringFAERS: 8US FAERS
212Wrong technique in drug usage processFAERS: 8OFFSIDES
US FAERS
213Accidental exposure to product by childFAERS: 7US FAERS
214BronchitisFAERS: 7OFFSIDES
US FAERS
215BruxismFAERS: 7US FAERS
216ChillsFAERS: 7SIDER
US FAERS
217ChokingFAERS: 7US FAERS
218Circumstance or information capable of leading to medication errorFAERS: 7US FAERS
219CyanosisFAERS: 7US FAERS
220Drug effective for unapproved indicationFAERS: 7US FAERS
221DysphemiaFAERS: 7US FAERS
222DysuriaFAERS: 7OFFSIDES
SIDER
US FAERS
223FlatulenceFAERS: 7US FAERS
224FlushingFAERS: 7US FAERS
225InfarctionFAERS: 7US FAERS
226Joint injuryFAERS: 7OFFSIDES
US FAERS
227Limb discomfortFAERS: 7US FAERS
228Oropharyngeal painFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
229Prescription form tamperingFAERS: 7US FAERS
230Product counterfeitFAERS: 7US FAERS
231Product dispensing errorFAERS: 7US FAERS
232Product label issueFAERS: 7US FAERS
233Product size issueFAERS: 7US FAERS
234Reaction to excipientFAERS: 7US FAERS
235SinusitisFAERS: 7OFFSIDES
US FAERS
236SomnambulismFAERS: 7US FAERS
237TachyphreniaFAERS: 7US FAERS
238TensionFAERS: 7SIDER
US FAERS
239Acute Coronary SyndromeFAERS: 6OFFSIDES
US FAERS
240Bone painFAERS: 6US FAERS
241DisabilityFAERS: 6US FAERS
242Drug level increasedFAERS: 6US FAERS
243EructationFAERS: 6US FAERS
244GastritisFAERS: 6US FAERS
245Hallucinations, mixedFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
246Incorrect drug administration durationFAERS: 6OFFSIDES
US FAERS
247Joint swellingFAERS: 6US FAERS
248LymphadenopathyFAERS: 6US FAERS
249Paradoxical drug reactionFAERS: 6US FAERS
250PresyncopeFAERS: 6US FAERS
251Product formulation issueFAERS: 6US FAERS
252Psychomotor skills impairedFAERS: 6US FAERS
253ScreamingFAERS: 6US FAERS
254Sinus TachycardiaFAERS: 6SIDER
US FAERS
255Therapeutic product effect incompleteFAERS: 6US FAERS
256ThrombocytopeniaFAERS: 6US FAERS
257Unresponsive to stimuliFAERS: 6OFFSIDES
US FAERS
258Urinary tract infectionFAERS: 6US FAERS
259Acute kidney injuryFAERS: 5US FAERS
260Angle Closure GlaucomaFAERS: 5US FAERS
261AphasiaFAERS: 5US FAERS
262Blood cholesterol abnormalFAERS: 5US FAERS
263CachexiaFAERS: 5US FAERS
264Cerebral disorderFAERS: 5US FAERS
265Disease recurrenceFAERS: 5US FAERS
266Drug clearance decreasedFAERS: 5US FAERS
267Eye irritationFAERS: 5US FAERS
268Gait inabilityFAERS: 5US FAERS
269Gastrointestinal PainFAERS: 5SIDER
US FAERS
270Head discomfortFAERS: 5US FAERS
271HyporeflexiaFAERS: 5
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
272HypoxiaFAERS: 511815692CTD
US FAERS
273Inappropriate affectFAERS: 5US FAERS
274LabyrinthitisFAERS: 5US FAERS
275Libido disorderFAERS: 5US FAERS
276Limb injuryFAERS: 5OFFSIDES
US FAERS
277Multiple drug overdose intentionalFAERS: 5US FAERS
278Neonatal disorderFAERS: 5US FAERS
279OsteoporosisFAERS: 5US FAERS
280PancreatitisFAERS: 5OFFSIDES
US FAERS
281Peripheral swellingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
282Pharyngolaryngeal PainFAERS: 5SIDER
US FAERS
283Product complaintFAERS: 5US FAERS
284Quality of life decreasedFAERS: 5US FAERS
285Respiratory FailureFAERS: 5US FAERS
286RetchingFAERS: 5US FAERS
287Rotator cuff syndromeFAERS: 5US FAERS
288Sexual DysfunctionFAERS: 5SIDER
US FAERS
289ShockFAERS: 5SIDER
US FAERS
290StuporFAERS: 5SIDER
US FAERS
291Therapeutic response changedFAERS: 5US FAERS
292Vitreous floatersFAERS: 5US FAERS
293White blood cell count decreasedFAERS: 5US FAERS
294Abnormal sleep-related eventFAERS: 4US FAERS
295Acute respiratory failureFAERS: 4OFFSIDES
US FAERS
296Alanine Aminotransferase IncreasedFAERS: 4US FAERS
297Allergic reaction to excipientFAERS: 4US FAERS
298BronchospasmFAERS: 4US FAERS
299Cerebral atrophyFAERS: 4OFFSIDES
US FAERS
300Chemical submissionFAERS: 4US FAERS
301Conversion disorderFAERS: 4US FAERS
302Counterfeit drug administeredFAERS: 4US FAERS
303CystitisFAERS: 4US FAERS
304DissociationFAERS: 4US FAERS
305DiverticulitisFAERS: 4OFFSIDES
US FAERS
306Gastric ulcerFAERS: 4OFFSIDES
US FAERS
307Gluten sensitivityFAERS: 4US FAERS
308HepatotoxicityFAERS: 4US FAERS
309HungerFAERS: 4US FAERS
310HyperacusisFAERS: 4US FAERS
311Incorrect route of drug administrationFAERS: 4US FAERS
312Initial insomniaFAERS: 4US FAERS
313LacerationFAERS: 4US FAERS
314Lyme DiseaseFAERS: 4US FAERS
315Macular degenerationFAERS: 4US FAERS
316Maternal exposure timing unspecifiedFAERS: 4US FAERS
317Medication residueFAERS: 4US FAERS
318Nasal discomfortFAERS: 4US FAERS
319NephrolithiasisFAERS: 4US FAERS
320PallorFAERS: 4US FAERS
321Papillary muscle disorderFAERS: 4US FAERS
322Prescribed overdoseFAERS: 4US FAERS
323Product physical consistency issueFAERS: 4US FAERS
324Rebound effectFAERS: 4US FAERS
325RhabdomyolysisFAERS: 4OFFSIDES
US FAERS
326SepsisFAERS: 4US FAERS
327SoliloquyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
328StaringFAERS: 4US FAERS
329Tardive DyskinesiaFAERS: 4US FAERS
330Tension HeadacheFAERS: 4US FAERS
331TheftFAERS: 4US FAERS
332Therapeutic product effect decreasedFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
333Transcription medication errorFAERS: 4US FAERS
334UlcerFAERS: 4OFFSIDES
US FAERS
335Wrong drug administeredFAERS: 4US FAERS
336Accidental drug intake by childFAERS: 3US FAERS
337AgeusiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
338Alcohol withdrawal syndromeFAERS: 3US FAERS
339AnhedoniaFAERS: 3OFFSIDES
US FAERS
340AphoniaFAERS: 3US FAERS
341Blood alcohol increasedFAERS: 3US FAERS
342Blood creatinine increasedFAERS: 3US FAERS
343Cardiac FlutterFAERS: 3US FAERS
344Cerebellar AtaxiaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
345Choking sensationFAERS: 3OFFSIDES
SIDER
US FAERS
346ClumsinessFAERS: 3SIDER
US FAERS
347Coma scale abnormalFAERS: 3US FAERS
348Coronary no-reflow phenomenonFAERS: 3US FAERS
349CystFAERS: 3US FAERS
350Diet refusalFAERS: 3US FAERS
351Drug administered to patient of inappropriate ageFAERS: 3US FAERS
352Drug dispensed to wrong patientFAERS: 3US FAERS
353DysphoniaFAERS: 3OFFSIDES
SIDER
US FAERS
354Economic problemFAERS: 3OFFSIDES
US FAERS
355Erythema MultiformeFAERS: 3SIDER
US FAERS
356Food AllergyFAERS: 3US FAERS
357FormicationFAERS: 3OFFSIDES
US FAERS
358FractureFAERS: 3US FAERS
359General physical condition abnormalFAERS: 3US FAERS
360Glossopharyngeal Nerve DisorderFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
361HepatomegalyFAERS: 3US FAERS
362Hormone level abnormalFAERS: 3US FAERS
363HyperphagiaFAERS: 3US FAERS
364Hypertensive crisisFAERS: 3US FAERS
365HyperthyroidismFAERS: 3US FAERS
366HypothyroidismFAERS: 3US FAERS
367Impaired self-careFAERS: 3US FAERS
368Incorrect product administration durationFAERS: 3US FAERS
369Intervertebral Disc DegenerationFAERS: 3OFFSIDES
US FAERS
370Intrusive thoughtsFAERS: 3US FAERS
371Joint stiffnessFAERS: 3US FAERS
372Lactose IntoleranceFAERS: 3US FAERS
373LaryngitisFAERS: 3US FAERS
374Ligament injuryFAERS: 3US FAERS
375Lip and/or oral cavity cancerFAERS: 3US FAERS
376Lip swellingFAERS: 3US FAERS
377LymphomaFAERS: 3OFFSIDES
US FAERS
378Multiple SclerosisFAERS: 3OFFSIDES
US FAERS
379Multiple drug overdoseFAERS: 3OFFSIDES
US FAERS
380Musculoskeletal discomfortFAERS: 3OFFSIDES
SIDER
US FAERS
381MutismFAERS: 3US FAERS
382MyoclonusFAERS: 3US FAERS
383NasopharyngitisFAERS: 3OFFSIDES
SIDER
US FAERS
384Night sweatsFAERS: 3US FAERS
385PeritonitisFAERS: 3US FAERS
386PneumothoraxFAERS: 3US FAERS
387PolydipsiaFAERS: 3US FAERS
388PosturingFAERS: 3US FAERS
389PregnancyFAERS: 3US FAERS
390Saliva alteredFAERS: 3US FAERS
391SarcomaFAERS: 3US FAERS
392SciaticaFAERS: 3US FAERS
393Sinus bradycardiaFAERS: 3US FAERS
394Skin irritationFAERS: 3US FAERS
395Skin reactionFAERS: 3US FAERS
396Status EpilepticusFAERS: 314644903CTD
US FAERS
397Sudden onset of sleepFAERS: 3US FAERS
398Therapy changeFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
399Therapy non-responderFAERS: 3US FAERS
400Tongue bitingFAERS: 3US FAERS
401Vagus Nerve DisorderFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
402Vitamin D DeficiencyFAERS: 3US FAERS
403Wrong drugFAERS: 3US FAERS
404Abdominal tendernessFAERS: 2US FAERS
405Accidental exposureFAERS: 2US FAERS
406Allergic sinusitisFAERS: 2US FAERS
407AneurysmFAERS: 2OFFSIDES
US FAERS
408AngioedemaFAERS: 216987489CTD
SIDER
US FAERS
409Anion gap abnormalFAERS: 2US FAERS
410AnorexiaFAERS: 2SIDER
US FAERS
411Aortic AneurysmFAERS: 2US FAERS
412AscitesFAERS: 2US FAERS
413Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
414AsphyxiaFAERS: 2OFFSIDES
US FAERS
415Atrioventricular BlockFAERS: 2US FAERS
416Atypical attention deficit syndromeFAERS: 2US FAERS
417Benign Prostatic HyperplasiaFAERS: 2US FAERS
418Bipolar II disorderFAERS: 2US FAERS
419BlepharospasmFAERS: 2US FAERS
420BlindnessFAERS: 2US FAERS
421Blood creatine phosphokinase MB increasedFAERS: 2US FAERS
422Blood creatinine abnormalFAERS: 2US FAERS
423Blood ketone body increasedFAERS: 2US FAERS
424Blood prolactin increasedFAERS: 2US FAERS
425Blood sodium decreasedFAERS: 2US FAERS
426Blood urea abnormalFAERS: 2US FAERS
427Borderline Personality DisorderFAERS: 2US FAERS
428BoredomFAERS: 2US FAERS
429Bowel movement irregularityFAERS: 2US FAERS
430BronchopneumoniaFAERS: 2OFFSIDES
US FAERS
431Central nervous system lesionFAERS: 2US FAERS
432Cervix carcinomaFAERS: 2US FAERS
433Cleft uvulaFAERS: 2US FAERS
434Congenital neurological disorderFAERS: 2US FAERS
435ConjunctivitisFAERS: 2US FAERS
436Dengue FeverFAERS: 2US FAERS
437Dental cariesFAERS: 2OFFSIDES
US FAERS
438Depression suicidalFAERS: 2US FAERS
439Drug effect variableFAERS: 2US FAERS
440Drug screen false positiveFAERS: 2US FAERS
441Drug withdrawal headacheFAERS: 2OFFSIDES
US FAERS
442Dry skinFAERS: 2US FAERS
443Ductus arteriosus premature closureFAERS: 2US FAERS
444DysenteryFAERS: 2US FAERS
445DyslaliaFAERS: 2US FAERS
446DyslexiaFAERS: 2US FAERS
447DystoniaFAERS: 2US FAERS
448Excessive ocular convergenceFAERS: 2US FAERS
449ExcoriationFAERS: 2OFFSIDES
US FAERS
450Exposure during breast feedingFAERS: 2US FAERS
451Extra dose administeredFAERS: 2US FAERS
452Flat affectFAERS: 2SIDER
US FAERS
453FrustrationFAERS: 2US FAERS
454Gastrointestinal carcinomaFAERS: 2US FAERS
455GingivitisFAERS: 2US FAERS
456Head BangingFAERS: 2US FAERS
457HerniaFAERS: 2OFFSIDES
US FAERS
458HypercapniaFAERS: 2US FAERS
459HypervigilanceFAERS: 2US FAERS
460Impaired quality of lifeFAERS: 2US FAERS
461ImpatienceFAERS: 2US FAERS
462Increased upper airway secretionFAERS: 2US FAERS
463InflammationFAERS: 2US FAERS
464Intentional dose omissionFAERS: 2US FAERS
465Intentional misuseFAERS: 2US FAERS
466Intercepted drug dispensing errorFAERS: 2US FAERS
467Intervertebral disc disorderFAERS: 2US FAERS
468Intracranial AneurysmFAERS: 2US FAERS
469Irregular breathingFAERS: 2US FAERS
470Limb crushing injuryFAERS: 2US FAERS
471Low density lipoprotein increasedFAERS: 2US FAERS
472MastitisFAERS: 2US FAERS
473Medication residue presentFAERS: 2US FAERS
474Mental RetardationFAERS: 2SIDER
US FAERS
475Metabolic acidosisFAERS: 2OFFSIDES
US FAERS
476Muscle RigidityFAERS: 2SIDER
US FAERS
477Musculoskeletal PainFAERS: 2OFFSIDES
US FAERS
478Musculoskeletal chest painFAERS: 2US FAERS
479NegativismFAERS: 2US FAERS
480NeutropeniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
481No adverse effectFAERS: 2US FAERS
482No adverse reactionFAERS: 2US FAERS
483NocturiaFAERS: 2OFFSIDES
US FAERS
484Oral painFAERS: 2US FAERS
485Oropharyngeal discomfortFAERS: 2US FAERS
486Oxygen consumption decreasedFAERS: 2US FAERS
487Persistent depressive disorderFAERS: 2US FAERS
488Post procedural complicationFAERS: 2US FAERS
489Posterior reversible encephalopathy syndromeFAERS: 2US FAERS
490Pregnancy test false positiveFAERS: 2US FAERS
491Pregnancy test positiveFAERS: 2US FAERS
492Product measured potency issueFAERS: 2US FAERS
493Product name confusionFAERS: 2US FAERS
494Product packaging issueFAERS: 2US FAERS
495Product prescribing issueFAERS: 2US FAERS
496Product tamperingFAERS: 2US FAERS
497PsoriasisFAERS: 2US FAERS
498Pupillary light reflex tests abnormalFAERS: 2US FAERS
499Reflux gastritisFAERS: 2US FAERS
500Retinal DetachmentFAERS: 2US FAERS
501Retrograde amnesiaFAERS: 2US FAERS
502Rheumatoid ArthritisFAERS: 2US FAERS
503Right Ventricular HypertrophyFAERS: 2US FAERS
504Right ventricular failureFAERS: 2US FAERS
505Ruptured cerebral aneurysmFAERS: 2US FAERS
506Salivary gland painFAERS: 2US FAERS
507SchizophreniaFAERS: 2
Canada Vigilance: 1
10464538CTD
Canada Vigilance
US FAERS
508SclerodermaFAERS: 2US FAERS
509Seizure like phenomenaFAERS: 2US FAERS
510Slow response to stimuliFAERS: 2US FAERS
511SneezingFAERS: 2US FAERS
512Splenic RuptureFAERS: 2US FAERS
513Teeth brittleFAERS: 2US FAERS
514Therapy cessationFAERS: 2US FAERS
515Throat cancerFAERS: 2US FAERS
516Toe operationFAERS: 2US FAERS
517ToothacheFAERS: 2US FAERS
518TrismusFAERS: 2US FAERS
519Troponin increasedFAERS: 2US FAERS
520Ventricular hypokinesiaFAERS: 2US FAERS
521Victim of homicideFAERS: 2US FAERS
522Victim of sexual abuseFAERS: 2US FAERS
523Vulvovaginal drynessFAERS: 2US FAERS
524Walking aid userFAERS: 2US FAERS
525Wheelchair userFAERS: 2OFFSIDES
US FAERS
526WheezingFAERS: 2US FAERS
527Withdrawal catatoniaFAERS: 2US FAERS
528Wrong product administeredFAERS: 2US FAERS
529treatment failureFAERS: 2US FAERS
530AbuliaFAERS: 1US FAERS
531Accidental deathFAERS: 1OFFSIDES
US FAERS
532AcneFAERS: 1US FAERS
533Acute psychosisFAERS: 1US FAERS
534AkathisiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
535Alanine aminotransferase abnormalFAERS: 1US FAERS
536Allergy to chemicalsFAERS: 1US FAERS
537Altered visual depth perceptionFAERS: 1US FAERS
538AmputationFAERS: 1US FAERS
539Anal FissureFAERS: 1US FAERS
540Ankle FractureFAERS: 1US FAERS
541AnosmiaFAERS: 1US FAERS
542Antidepressant drug level increasedFAERS: 1US FAERS
543Antinuclear antibody increasedFAERS: 1US FAERS
544AphagiaFAERS: 1US FAERS
545AppendicitisFAERS: 1US FAERS
546Arthropod biteFAERS: 1US FAERS
547AsthenopiaFAERS: 1US FAERS
548Auricular swellingFAERS: 1US FAERS
549Autoimmune thyroiditisFAERS: 1OFFSIDES
US FAERS
550Autonomic nervous system imbalanceFAERS: 1US FAERS
551Bipolar I disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
552Bladder painFAERS: 1US FAERS
553Blood albumin decreasedFAERS: 1US FAERS
554Blood alcohol abnormalFAERS: 1US FAERS
555Blood alcoholFAERS: 1US FAERS
556Blood calcium abnormalFAERS: 1US FAERS
557Blood cortisol increasedFAERS: 1US FAERS
558Blood creatine increasedFAERS: 1US FAERS
559Blood ethanol increasedFAERS: 1US FAERS
560Blood glucose abnormalFAERS: 1US FAERS
561Blood magnesium decreasedFAERS: 1US FAERS
562Blood magnesium increasedFAERS: 1US FAERS
563Blood sodium increasedFAERS: 1US FAERS
564Blood testosterone decreasedFAERS: 1US FAERS
565Blood triglycerides abnormalFAERS: 1US FAERS
566Blood triglycerides increasedFAERS: 1OFFSIDES
US FAERS
567Blood urea increasedFAERS: 1US FAERS
568Blood urine presentFAERS: 1US FAERS
569Blunted affectFAERS: 1US FAERS
570Brain DeathFAERS: 1OFFSIDES
US FAERS
571Brain natriuretic peptide increasedFAERS: 1US FAERS
572Breath alcohol test positiveFAERS: 1US FAERS
573Bronchial ObstructionFAERS: 1US FAERS
574Burning Mouth SyndromeFAERS: 1US FAERS
575BursitisFAERS: 1OFFSIDES
US FAERS
576Cancer PainFAERS: 1US FAERS
577Cardiac discomfortFAERS: 1US FAERS
578Cardiac ventricular disorderFAERS: 1US FAERS
579CardiomegalyFAERS: 1US FAERS
580Cartilage injuryFAERS: 1US FAERS
581Cataract operationFAERS: 1OFFSIDES
US FAERS
582Catheter site infectionFAERS: 1US FAERS
583Cerebral InfarctionFAERS: 1US FAERS
584ChromaturiaFAERS: 1US FAERS
585Chronic sinusitisFAERS: 1US FAERS
586Cleft PalateFAERS: 1US FAERS
587ClinodactylyFAERS: 1US FAERS
588Clostridium colitisFAERS: 1US FAERS
589Coating in mouthFAERS: 1US FAERS
590Cogwheel RigidityFAERS: 1US FAERS
591Complex partial seizuresFAERS: 1US FAERS
592Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
593Compression fractureFAERS: 1US FAERS
594Contraindicated product administeredFAERS: 1US FAERS
595Corneal erosionFAERS: 1US FAERS
596Coronary Artery DiseaseFAERS: 1US FAERS
597Cubital Tunnel SyndromeFAERS: 1US FAERS
598Death of relativeFAERS: 1US FAERS
599Deep Vein ThrombosisFAERS: 1US FAERS
600Delusional perceptionFAERS: 1US FAERS
601DemyelinationFAERS: 1OFFSIDES
US FAERS
602Dental FistulaFAERS: 1US FAERS
603Dental discomfortFAERS: 1US FAERS
604Denture wearerFAERS: 1OFFSIDES
US FAERS
605Device related sepsisFAERS: 1US FAERS
606Device use errorFAERS: 1US FAERS
607Diabetes mellitus inadequate controlFAERS: 1OFFSIDES
US FAERS
608Disease ProgressionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
609Disruptive mood dysregulation disorderFAERS: 1US FAERS
610DiverticulumFAERS: 1OFFSIDES
US FAERS
611DroolingFAERS: 1US FAERS
612DrowningFAERS: 1US FAERS
613Drug diversionFAERS: 1US FAERS
614Drug exposure via breast milkFAERS: 1US FAERS
615Drug level above therapeuticFAERS: 1US FAERS
616Drug level below therapeuticFAERS: 1US FAERS
617Drug level changedFAERS: 1US FAERS
618Drug resistanceFAERS: 1US FAERS
619DysbacteriosisFAERS: 1US FAERS
620DyscheziaFAERS: 1OFFSIDES
US FAERS
621DysmorphismFAERS: 1US FAERS
622DyspareuniaFAERS: 1US FAERS
623Ear discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
624Echography abnormalFAERS: 1US FAERS
625EczemaFAERS: 1US FAERS
626Elder AbuseFAERS: 1US FAERS
627Electroencephalogram abnormalFAERS: 1US FAERS
628Endocardial FibroelastosisFAERS: 1US FAERS
629EnuresisFAERS: 17802851CTD
US FAERS
630EosinophiliaFAERS: 1US FAERS
631Erection increasedFAERS: 1US FAERS
632Exaggerated startle responseFAERS: 1US FAERS
633Excessive eye blinkingFAERS: 1US FAERS
634Exfoliation SyndromeFAERS: 1US FAERS
635Extraocular Muscle ParesisFAERS: 1US FAERS
636Eyelid painFAERS: 1US FAERS
637Facial PainFAERS: 1US FAERS
638Facial wastingFAERS: 1US FAERS
639Failure to ThriveFAERS: 1US FAERS
640Feeding disorder neonatalFAERS: 1US FAERS
641Feeding tube complicationFAERS: 1US FAERS
642Feelings of worthlessnessFAERS: 1US FAERS
643Finger hypoplasiaFAERS: 1US FAERS
644Flight of ideasFAERS: 1US FAERS
645Foaming at mouthFAERS: 1US FAERS
646Food PoisoningFAERS: 1US FAERS
647Foreign body in respiratory tractFAERS: 1US FAERS
648Fracture painFAERS: 1US FAERS
649Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
650Gastric FistulaFAERS: 1US FAERS
651GastroenteritisFAERS: 1US FAERS
652Gastrointestinal hypomotilityFAERS: 1US FAERS
653Gastrointestinal lymphomaFAERS: 1US FAERS
654Gastrointestinal motility disorderFAERS: 1US FAERS
655GastroschisisFAERS: 1US FAERS
656Genital dischargeFAERS: 1US FAERS
657Glutamate dehydrogenase increasedFAERS: 1US FAERS
658Grief reactionFAERS: 1US FAERS
659Grip strength decreasedFAERS: 1US FAERS
660Group B streptococcus neonatal sepsisFAERS: 1US FAERS
661Hand-eye coordination impairedFAERS: 1US FAERS
662HemicephalalgiaFAERS: 1US FAERS
663Hepatic EncephalopathyFAERS: 1US FAERS
664Hepatitis CFAERS: 1OFFSIDES
US FAERS
665HidradenitisFAERS: 1US FAERS
666Human chorionic gonadotropin increasedFAERS: 1US FAERS
667HypometabolismFAERS: 1US FAERS
668HypopituitarismFAERS: 1US FAERS
669Hypothalamo-pituitary disorderFAERS: 1US FAERS
670HypoventilationFAERS: 1US FAERS
671HysterectomyFAERS: 1US FAERS
672Iatrogenic injuryFAERS: 1OFFSIDES
US FAERS
673IleusFAERS: 1US FAERS
674Inappropriate schedule of product administrationFAERS: 1US FAERS
675IncoherentFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
676IncontinenceFAERS: 1OFFSIDES
SIDER
US FAERS
677Infective exacerbation of chronic obstructive airways diseaseFAERS: 1US FAERS
678Injection site ulcerFAERS: 1US FAERS
679Intellectual DisabilityFAERS: 1US FAERS
680Intercepted drug administration errorFAERS: 1US FAERS
681Intercepted product administration errorFAERS: 1US FAERS
682Intercepted product selection errorFAERS: 1US FAERS
683Intraocular pressure testFAERS: 1US FAERS
684Joint InstabilityFAERS: 1US FAERS
685Joint Range of Motion DecreasedFAERS: 1US FAERS
686Joint destructionFAERS: 1US FAERS
687Joint sprainFAERS: 1OFFSIDES
US FAERS
688Labile blood pressureFAERS: 1US FAERS
689Large intestine perforationFAERS: 1OFFSIDES
US FAERS
690Latex allergyFAERS: 1US FAERS
691LazinessFAERS: 1US FAERS
692LeukoencephalopathyFAERS: 1US FAERS
693LeukopeniaFAERS: 1US FAERS
694Ligament ruptureFAERS: 1US FAERS
695LigamentitisFAERS: 1US FAERS
696Lipase increasedFAERS: 1US FAERS
697LipomaFAERS: 1US FAERS
698Locked-In SyndromeFAERS: 1US FAERS
699Long QT SyndromeFAERS: 1US FAERS
700LymphopeniaFAERS: 1US FAERS
701Macular fibrosisFAERS: 1US FAERS
702Magnesium DeficiencyFAERS: 1US FAERS
703MalabsorptionFAERS: 1US FAERS
704Malignant HypertensionFAERS: 1US FAERS
705MalnutritionFAERS: 1SIDER
US FAERS
706Manufacturing issueFAERS: 1US FAERS
707Manufacturing materials issueFAERS: 1US FAERS
708Markedly reduced dietary intakeFAERS: 1US FAERS
709Mastication disorderFAERS: 1OFFSIDES
US FAERS
710Mental FatigueFAERS: 1US FAERS
711MetastasisFAERS: 1US FAERS
712Metastatic NeoplasmFAERS: 1OFFSIDES
US FAERS
713Micturition frequency decreasedFAERS: 1US FAERS
714Milk AllergyFAERS: 1US FAERS
715Mitochondrial toxicityFAERS: 1US FAERS
716MoaningFAERS: 1US FAERS
717MonoparesisFAERS: 1US FAERS
718Morbid thoughtsFAERS: 1US FAERS
719Motion SicknessFAERS: 1US FAERS
720Multiple Chemical SensitivityFAERS: 1US FAERS
721Muscle SpasticityFAERS: 1SIDER
US FAERS
722Muscle strainFAERS: 1US FAERS
723Myasthenia GravisFAERS: 1US FAERS
724Myasthenic SyndromeFAERS: 1US FAERS
725MyopiaFAERS: 1US FAERS
726NecrosisFAERS: 119490937CTD
US FAERS
727Neonatal infectionFAERS: 1US FAERS
728NephrosclerosisFAERS: 1US FAERS
729NeuritisFAERS: 1US FAERS
730Neuroleptic Malignant SyndromeFAERS: 116720068CTD
US FAERS
731Neutrophil count decreasedFAERS: 1US FAERS
732Obsessive thoughtsFAERS: 1US FAERS
733Occupational physical problemFAERS: 1US FAERS
734Ocular icterusFAERS: 1US FAERS
735Oral fungal infectionFAERS: 1US FAERS
736Oropharyngeal swellingFAERS: 1US FAERS
737OsteolysisFAERS: 1US FAERS
738Ovarian adhesionFAERS: 1US FAERS
739PapuleFAERS: 1US FAERS
740Paranasal sinus hypersecretionFAERS: 1US FAERS
741Parent-child problemFAERS: 1US FAERS
742Pectus excavatumFAERS: 1US FAERS
743Pelvic discomfortFAERS: 1US FAERS
744PeriarthritisFAERS: 1US FAERS
745PeriodontitisFAERS: 1US FAERS
746Peripheral arterial occlusive diseaseFAERS: 1OFFSIDES
US FAERS
747PharyngitisFAERS: 1US FAERS
748PhonophobiaFAERS: 1US FAERS
749PhytotherapyFAERS: 1US FAERS
750Pilonidal CystFAERS: 1US FAERS
751PolyneuropathyFAERS: 1OFFSIDES
US FAERS
752Poverty of speechFAERS: 1US FAERS
753Procedural complicationFAERS: 1US FAERS
754Product availability issueFAERS: 1US FAERS
755Product coating issueFAERS: 1US FAERS
756Product compounding quality issueFAERS: 1US FAERS
757Product dosage form issueFAERS: 1US FAERS
758Product dose omissionFAERS: 1US FAERS
759Product friableFAERS: 1US FAERS
760Product lot number issueFAERS: 1US FAERS
761Product packaging counterfeitFAERS: 1US FAERS
762Product storage errorFAERS: 1US FAERS
763Product substitutionFAERS: 1US FAERS
764Product supply issueFAERS: 1US FAERS
765Product use complaintFAERS: 1US FAERS
766Pulmonary FibrosisFAERS: 1US FAERS
767Pupillary deformityFAERS: 1US FAERS
768PurulenceFAERS: 1US FAERS
769Rash erythematousFAERS: 1US FAERS
770Reaction to azo-dyesFAERS: 1US FAERS
771Reaction to medical agent preservativesFAERS: 1US FAERS
772Rectal dischargeFAERS: 1US FAERS
773Renal cystFAERS: 1OFFSIDES
US FAERS
774Respiratory tract congestionFAERS: 1US FAERS
775RetrognathiaFAERS: 1US FAERS
776RhinalgiaFAERS: 1US FAERS
777RhinitisFAERS: 1US FAERS
778Saliva analysis abnormalFAERS: 1US FAERS
779ScabFAERS: 1US FAERS
780Schizotypal Personality DisorderFAERS: 1US FAERS
781Sedation complicationFAERS: 1US FAERS
782Self MutilationFAERS: 1US FAERS
783Septic ShockFAERS: 1US FAERS
784Serotonin SyndromeFAERS: 1US FAERS
785Sexual abuseFAERS: 1US FAERS
786Shoulder PainFAERS: 1US FAERS
787Sjogren's SyndromeFAERS: 1US FAERS
788Skeletal injuryFAERS: 1OFFSIDES
US FAERS
789Skin UlcerFAERS: 1US FAERS
790Skin lacerationFAERS: 1US FAERS
791Spinal column stenosisFAERS: 1OFFSIDES
US FAERS
792Spontaneous penile erectionFAERS: 1US FAERS
793Stevens-Johnson SyndromeFAERS: 125811541CTD
SIDER
US FAERS
794StomatitisFAERS: 1US FAERS
795Suspected product tamperingFAERS: 1US FAERS
796Suspected suicide attemptFAERS: 1US FAERS
797Tablet physical issueFAERS: 1US FAERS
798Temperature regulation disorderFAERS: 1US FAERS
799TetanyFAERS: 1US FAERS
800Therapeutic product effect delayedFAERS: 1US FAERS
801Therapeutic product effect variableFAERS: 1US FAERS
802Therapeutic product ineffectiveFAERS: 1US FAERS
803ThermohypoaesthesiaFAERS: 1US FAERS
804Thrombotic strokeFAERS: 1US FAERS
805Thyroid malformationFAERS: 1US FAERS
806ThyroiditisFAERS: 1US FAERS
807Tissue ruptureFAERS: 1US FAERS
808Tongue blisteringFAERS: 1US FAERS
809Tongue discomfortFAERS: 1US FAERS
810Tongue exfoliationFAERS: 1US FAERS
811Tooth LossFAERS: 1OFFSIDES
US FAERS
812TorticollisFAERS: 1US FAERS
813Toxic Epidermal NecrolysisFAERS: 1US FAERS
814Toxic leukoencephalopathyFAERS: 1US FAERS
815Toxicologic test abnormalFAERS: 1US FAERS
816Transaminases increasedFAERS: 1US FAERS
817Tryptase increasedFAERS: 1US FAERS
818Umbilical herniaFAERS: 1US FAERS
819UnderweightFAERS: 1US FAERS
820Unexpected therapeutic drug effectFAERS: 1US FAERS
821Urine flow decreasedFAERS: 1US FAERS
822Vascular bypass graftFAERS: 1US FAERS
823Vascular occlusionFAERS: 1US FAERS
824Vascular painFAERS: 1US FAERS
825Violence-related symptomFAERS: 1US FAERS
826Visual disturbanceFAERS: 1US FAERS
827Vitamin B6 increasedFAERS: 1US FAERS
828Vulvovaginal burning sensationFAERS: 1US FAERS
829Waxy flexibilityFAERS: 1US FAERS
830Williams SyndromeFAERS: 1US FAERS
831Wound InfectionFAERS: 1US FAERS
832Wrist deformityFAERS: 1US FAERS
833furuncleFAERS: 1US FAERS
834insulinomaFAERS: 1US FAERS
835prostatitisFAERS: 1US FAERS
836Abdominal distressSIDER
837Abnormal visionOFFSIDES
838AbscessOFFSIDES
839AbuseOFFSIDES
840Acid refluxOFFSIDES
841ActinomycosisOFFSIDES
842Acute otitis mediaOFFSIDES
843Akathisia, Drug-Induced16513883CTD
844Ammonia increasedOFFSIDES
845AnalgesiaOFFSIDES
846Anaphylactoid ReactionCanada Vigilance: 1Canada Vigilance
847AngiolipomaOFFSIDES
848AnhidrosisOFFSIDES
849Anticonvulsant drug level below therapeuticOFFSIDES
850Anxiety Disorders

View details

CTD
851Aphthous StomatitisOFFSIDES
852ApneaOFFSIDES
853ArteriosclerosisOFFSIDES
854AuraOFFSIDES
855AutomatismOFFSIDES
856Basal cell carcinomaOFFSIDES
857BereavementOFFSIDES
858Bladder discomfortOFFSIDES
859Blood GlucoseOFFSIDES
860Blood chloride decreasedOFFSIDES
861Blood cholesterolOFFSIDES
862Blood glucose decreasedOFFSIDES
863Blood pressure inadequately controlledOFFSIDES
864Blurred visionOFFSIDES
865Bone SarcomaOFFSIDES
866Bone lesionOFFSIDES
867Bone swellingOFFSIDES
868Bullous lung diseaseOFFSIDES
869Catheter related complicationOFFSIDES
870CausalgiaOFFSIDES
871CellulitisOFFSIDES
872Chemical and Drug Induced Liver Injury2869702
3358644
CTD
873Chest tightnessSIDER
874Chronic Obstructive Airway DiseaseOFFSIDES
875Cognition Disorders11815692CTD
876ColitisCanada Vigilance: 1Canada Vigilance
OFFSIDES
877ConfabulationOFFSIDES
878Culture positiveOFFSIDES
879DebridementOFFSIDES
880Dental abscessOFFSIDES
881Depressive disorder

View details

CTD
882DermatitisSIDER
883DiabetesOFFSIDES
884Diabetic NephropathyOFFSIDES
885Diabetic RetinopathyOFFSIDES
886Disorders of Excessive Somnolence2858187
17097811
18635690
CTD
887Disorders of Sex Development7883836CTD
888Disseminated Intravascular Coagulation10464538CTD
889Disturbance in sexual arousalSIDER
890DiverticulosisOFFSIDES
891DrowsinessOFFSIDES
SIDER
892Drug addictOFFSIDES
893Drug half-life reducedCanada Vigilance: 1Canada Vigilance
894DuodenitisOFFSIDES
895Dysthymic DisorderOFFSIDES
896Ear and labyrinth disordersSIDER
897Ejection Fraction DecreasedOFFSIDES
898EncephalomalaciaOFFSIDES
899EndometriosisOFFSIDES
900EnteritisOFFSIDES
901Eustachian tube disorderOFFSIDES
902Eye InfectionOFFSIDES
903Fever11815692CTD
904Fluid overloadOFFSIDES
905Food cravingOFFSIDES
906GamblingOFFSIDES
907Gastrointestinal sounds abnormalOFFSIDES
908GranulocytosisOFFSIDES
909Hallucinations2397358
12923827
CTD
910Heart Block3224354CTD
911HepatitisSIDER
912High frequency ablationOFFSIDES
913Hyperprolactinemia8803653CTD
914Hypocoagulable stateOFFSIDES
915HypomaniaSIDER
916InfestationSIDER
917Infusion site mobility decreasedOFFSIDES
918Injection site dermatitisOFFSIDES
919Intention tremorOFFSIDES
920Intermittent ClaudicationOFFSIDES
921LightheadednessSIDER
922Lumbar radiculopathyOFFSIDES
923LymphedemaOFFSIDES
924Maxillofacial operationOFFSIDES
925Memory Disorders7802851
12388988
14644903
CTD
926Mental disorders3421354CTD
927Movement Disorders19519270CTD
928Multiple sclerosis relapseOFFSIDES
929Muscle WeaknessOFFSIDES
930Muscle relaxant therapySIDER
931Nephritic syndromeOFFSIDES
932Nephrogenic Fibrosing DermopathyOFFSIDES
933Nervous tensionOFFSIDES
934Non-cardiac chest painOFFSIDES
935NystagmusCanada Vigilance: 1Canada Vigilance
936Oral pruritusCanada Vigilance: 1Canada Vigilance
937Oropharyngeal blisteringOFFSIDES
938OsteomyelitisOFFSIDES
939OsteopeniaOFFSIDES
940OsteosclerosisOFFSIDES
941Pericardial effusionOFFSIDES
942PeriostitisOFFSIDES
943Personality Disorders2912273
8749839
12388988
CTD
944Phantom painOFFSIDES
945Physical disabilityOFFSIDES
946PneumoconiosisOFFSIDES
947Polymyalgia RheumaticaOFFSIDES
948Post inflammatory pigmentation changeOFFSIDES
949Post procedural painOFFSIDES
950Postoperative Complications1863727CTD
951Premenstrual syndromeSIDER
952Prenatal Exposure Delayed Effects12388988
12561965
CTD
953Primary sequestrumOFFSIDES
954Productive CoughOFFSIDES
955Proteinuria3622604CTD
956Psychotic Disorders2300914
2307974
CTD
957Pulmonary congestionOFFSIDES
958Pulmonary radiation injuryOFFSIDES
959PyuriaOFFSIDES
960Renal lipomatosisOFFSIDES
961Reticulocyte count increasedOFFSIDES
962Retinal Vascular DisorderOFFSIDES
963Retinal vascular thrombosisOFFSIDES
964SarcoidosisOFFSIDES
965Seizures

View details

CTD
966Sinus headacheOFFSIDES
967Skin lesionOFFSIDES
968Sleep Initiation and Maintenance Disorders15341891CTD
969Sleep TalkingSIDER
970Sleep Wake Disorders2307974
2335496
CTD
971Slurred speechSIDER
972Soft Tissue InjuriesOFFSIDES
973Spasm2307974CTD
974Speech Disorders3358644
19519270
CTD
975Splenic InfarctionOFFSIDES
976SpondylolisthesisOFFSIDES
977Subcutaneous noduleOFFSIDES
978Substance Withdrawal Syndrome

View details

CTD
979Substance-Related Disorders3258735CTD
980SuicideSIDER
981SweatingSIDER
982TalkativenessSIDER
983ThrombophlebitisOFFSIDES
984Tooth ExtractionOFFSIDES
985TracheitisOFFSIDES
986Urine output increasedOFFSIDES
987Vascular Diseases10464538CTD
988Vitreous DetachmentOFFSIDES
989Weight GainOFFSIDES
990Withdrawal seizuresSIDER
991jaundice2869702CTD
SIDER
992muscle injuryOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.